We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+0.11%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
–
AUM
$851M
AUM Growth
-$105M
Cap. Flow
+$44.2M
Cap. Flow %
5.19%
Top 10 Hldgs %
47.53%
Holding
835
New
170
Increased
157
Reduced
172
Closed
270

Top Buys

Rank Stock Value
1
KVSC
Khosla Ventures Acquisition Co. III Class A Common Stock
KVSC
+$24.3M
2
STOK icon
Stoke Therapeutics
STOK
+$22.8M
3
TIOA
Tio Tech A Class A Ordinary Share
TIOA
+$22.1M
4
SCPH
scPharmaceuticals
SCPH
+$20.6M
5
AAC
Ares Acquisition Corporation
AAC
+$13.3M

Top Sells

Rank Stock Value
1
DCP
DCP Midstream, LP
DCP
+$58.8M
2
SCPL
SciPlay Corporation Class A Common Stock
SCPL
+$25.2M
3
CTLP
Cantaloupe
CTLP
+$12.3M
4
INVZ icon
Innoviz Technologies
INVZ
+$10.9M
5
KAIR
Kairos Acquisition Corp. Class A Ordinary Shares
KAIR
+$8.76M

Sector Composition

Rank Sector Weight
1 Healthcare 38.46%
2 Financials 25.66%
3 Materials 12.69%
4 Consumer Discretionary 4.54%
5 Technology 2.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PTOCW
776
DELISTED
Pine Technology Acquisition Corp. Warrant
PTOCW
– –
-49,700
Closed -$84
HORIW
777
DELISTED
Emerging Markets Horizon Corp. Warrants
HORIW
– –
-197,371
Closed -$1.28K
ESM.WS
778
DELISTED
ESM Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
ESM.WS
– –
-112,865
Closed -$13.1K
HERAW
779
DELISTED
FTAC Hera Acquisition Corp. Warrant
HERAW
– –
-1,514,041
Closed -$41.6K
IBER.WS
780
DELISTED
Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
IBER.WS
– –
-250,974
Closed -$4.47K
RNERW
781
DELISTED
Mount Rainier Acquisition Corp. Warrant
RNERW
– –
-112,897
Closed -$20.3K
ANAC.WS
782
DELISTED
Arctos NorthStar Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
ANAC.WS
– –
-101,675
Closed -$4.3K
CINC
783
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
– –
-7,292
Closed -$89.6K
CINC
784
PUT
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
– –
-15,000
Closed -$25.9K
FTAAW
785
DELISTED
FTAC Athena Acquisition Corp. Warrant
FTAAW
– –
-139,718
Closed -$6.85K
NVSA
786
DELISTED
New Vista Acquisition Corp Class A Ordinary Shares
NVSA
– –
-55,532
Closed -$561K
NVSAW
787
DELISTED
New Vista Acquisition Corp. Warrant
NVSAW
– –
-96,438
Closed -$5.56K
LGACW
788
DELISTED
Lazard Growth Acquisition Corp. I Warrants
LGACW
– –
-58,661
Closed -$351
MSACW
789
DELISTED
Medicus Sciences Acquisition Corp. Warrant
MSACW
– –
-52,887
Closed -$4.76K
ITQRW
790
DELISTED
Itiquira Acquisition Corp. Warrant
ITQRW
– –
-74,608
Closed -$559
CTAQW
791
DELISTED
Carney Technology Acquisition Corp. II Warrant
CTAQW
– –
-16,400
Closed -$1.1K
WQGA
792
DELISTED
World Quantum Growth Acquisition Corp.
WQGA
– –
-22,200
Closed -$226K
SCOBW
793
DELISTED
ScION Tech Growth II Warrants
SCOBW
– –
-62,722
Closed -$225
BACA.WS
794
DELISTED
Berenson Acquisition Corp. I Warrants, each whole warrant exercisable for one share of class A common stock at an exercise price of $11.50
BACA.WS
– –
-111,272
Closed -$4.06K
SCMAW
795
DELISTED
Seaport Calibre Materials Acquisition Corp. Warrant
SCMAW
– –
-222,858
Closed -$7.8K
MIT
796
DELISTED
Mason Industrial Technology, Inc.
MIT
– –
-100,700
Closed -$1.01M
DTRT
797
DELISTED
DTRT Health Acquisition Corp. Class A Common Stock
DTRT
– –
-224,845
Closed -$2.33M
CPARW
798
DELISTED
Catalyst Partners Acquisition Corp. Warrant
CPARW
– –
-212,318
Closed -$360
DNZ.WS
799
DELISTED
D and Z Media Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
DNZ.WS
– –
-148,534
Closed -$7.63K
NAACW
800
DELISTED
North Atlantic Acquisition Corporation Warrant
NAACW
– –
-83,060
Closed -$1.7K
30 31
32
33 34

Similar funds

CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
PWLP
Prio Wealth Limited Partnership Boston, Massachusetts $3.41B AUM 44.09% 1-Year Est. Return
FPCG
Fort Pitt Capital Group Pittsburgh, Pennsylvania $3.55B AUM 34.86% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
FTDI
First Trust Direct Indexing Boston, Massachusetts $1.87B AUM 43.63% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 23.73% 1-Year Est. Return

Cowen and Company's Q1 2023 Portfolio in Review

As of Q1 2023, Cowen and Company held 835 positions worth $851M, down 11% from $956M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Cowen and Company deployed $44.2M of net new capital in Q1 2023, opening 170 new positions and adding to 157 existing holdings. Its largest new stake was Khosla Ventures Acquisition Co. III Class A Common Stock: 2,410,664 shares worth $24.5M.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 37% a quarter earlier, followed by Financials and Materials.

On the sell side, the largest reduction was SciPlay Corporation Class A Common Stock, an estimated $25.2M trimmed.

  • Cowen and Company's largest Q1 2023 buy was Khosla Ventures Acquisition Co. III Class A Common Stock: 2,410,664 shares worth $24.5M.
  • Cowen and Company added most to Stoke Therapeutics in Q1 2023, an estimated $22.8M increase.
  • Cowen and Company's biggest Q1 2023 reduction was SciPlay Corporation Class A Common Stock, cutting an estimated $25.2M.
  • Cowen and Company fully exited DCP Midstream, LP in Q1 2023, selling an estimated $58.8M.
  • Cowen and Company's ten largest holdings make up 48% of its $851M portfolio in Q1 2023.
  • Cowen and Company opened 170 new positions and closed 270 in Q1 2023.
  • Cowen and Company's portfolio value fell 11% quarter-over-quarter to $851M.

Based on Cowen and Company's 13F filing for Q1 2023, filed 9 May 2023.